• Thu, February 2, 2023

by: WOPRAI

Andrew Didora Maintained (ALGT) at Hold with Decreased Target to $85 on, Feb 2nd, 2023

by: WOPRAI

Helane Becker Maintained (ALGT) at Hold with Increased Target to $83 on, Feb 2nd, 2023

by: WOPRAI

Michael Linenberg Maintained (ALGT) at Hold with Increased Target to $85 on, Feb 2nd, 2023

by: WOPRAI

Jason Bednar Maintained (ALGN) at Buy with Increased Target to $360 on, Feb 2nd, 2023

by: WOPRAI

Jeff Johnson Maintained (ALGN) at Buy with Increased Target to $335 on, Feb 2nd, 2023

by: WOPRAI

Nathan Rice Upgraded (ALGN) to Hold and Held Target at $307 on, Feb 2nd, 2023

by: WOPRAI

Jonathan Block Maintained (ALGN) at Strong Buy with Increased Target to $375 on, Feb 2nd, 2023

by: WOPRAI

Elizabeth Anderson Maintained (ALGN) at Buy with Increased Target to $375 on, Feb 2nd, 2023

by: WOPRAI

Dori Kesten Maintained (SVC) at Sell with Increased Target to $7.5 on, Feb 2nd, 2023

by: WOPRAI

Matt Miksic Maintained (SYK) at Buy with Increased Target to $283 on, Feb 2nd, 2023

by: WOPRAI

John Staszak Downgraded (SYY) to Hold on, Feb 2nd, 2023

by: WOPRAI

Joseph Giordano Maintained (ST) at Buy with Increased Target to $63 on, Feb 2nd, 2023

by: WOPRAI

Matthew Thornton Maintained (SPOT) at Strong Buy with Increased Target to $132 on, Feb 2nd, 2023

by: WOPRAI

Joseph Altobello Maintained (SMG) at Strong Buy with Increased Target to $92 on, Feb 2nd, 2023

by: WOPRAI

Chris Carey Maintained (SMG) at Hold with Increased Target to $75 on, Feb 2nd, 2023

by: WOPRAI

Jeffrey Zekauskas Maintained (SMG) at Hold with Increased Target to $80 on, Feb 2nd, 2023

by: WOPRAI

Bill Chappell Maintained (SMG) at Hold with Increased Target to $70 on, Feb 2nd, 2023

by: WOPRAI

Peter Keith Maintained (SNBR) at Hold with Increased Target to $35 on, Feb 2nd, 2023

by: WOPRAI

Bill Katz Maintained (BX) at Sell with Decreased Target to $69 on, Feb 2nd, 2023

by: WOPRAI

Mike Matson Maintained (BSX) at Strong Buy with Increased Target to $53 on, Feb 2nd, 2023

by: WOPRAI

Jayson Bedford Maintained (BSX) at Strong Buy with Increased Target to $56 on, Feb 2nd, 2023

by: WOPRAI

Robbie Marcus Maintained (BSX) at Buy with Increased Target to $55 on, Feb 2nd, 2023

by: WOPRAI

Alex Rygiel Maintained (CCS) at Hold with Increased Target to $56 on, Feb 2nd, 2023

by: WOPRAI

Jay McCanless Maintained (CCS) at Buy with Decreased Target to $70 on, Feb 2nd, 2023

by: WOPRAI

James Ricchiuti Maintained (BHE) at Strong Buy with Decreased Target to $34 on, Feb 2nd, 2023

by: WOPRAI

Chris Kotowski Maintained (BAC) at Buy with Increased Target to $53 on, Feb 2nd, 2023

by: WOPRAI

Matthew Sharpe Maintained (BAH) at Buy with Decreased Target to $116 on, Feb 2nd, 2023

by: WOPRAI

Anthony Paolone Maintained (ARE) at Buy with Increased Target to $177 on, Feb 2nd, 2023

by: WOPRAI

David Rodgers Maintained (ARE) at Buy with Increased Target to $174 on, Feb 2nd, 2023

by: WOPRAI

Dori Kesten Maintained (APLE) at Hold with Increased Target to $18 on, Feb 2nd, 2023

by: WOPRAI

Jim Suva Maintained (AVT) at Hold with Increased Target to $50 on, Feb 2nd, 2023

by: WOPRAI

Joseph Cardoso Maintained (AVT) at Sell with Increased Target to $47 on, Feb 2nd, 2023

by: WOPRAI

Joseph Quatrochi Maintained (AVT) at Sell with Increased Target to $38 on, Feb 2nd, 2023

by: WOPRAI

Erik Suppiger Reiterated (AVNW) at Buy and Held Target at $50 on, Feb 2nd, 2023

by: WOPRAI

Dave Kang Maintained (AVNW) at Strong Buy with Increased Target to $58 on, Feb 2nd, 2023

by: WOPRAI

Andrew Kaplowitz Maintained (ATKR) at Hold with Increased Target to $156 on, Feb 2nd, 2023

by: WOPRAI

Alex Rygiel Maintained (ATKR) at Strong Buy with Increased Target to $161 on, Feb 2nd, 2023

by: WOPRAI

Deane Dray Maintained (ATKR) at Buy with Increased Target to $177 on, Feb 2nd, 2023

by: WOPRAI

Jeffrey Zekauskas Downgraded (ASH) to Sell and Increased Target to $105 on, Feb 2nd, 2023

by: WOPRAI

John McNulty Maintained (ASH) at Buy with Increased Target to $136 on, Feb 2nd, 2023

by: WOPRAI

Michael Sison Maintained (ASH) at Hold with Decreased Target to $115 on, Feb 2nd, 2023

by: WOPRAI

Catherine Mealor Maintained (CADE) at Buy with Decreased Target to $32 on, Feb 2nd, 2023

by: WOPRAI

Matthew Sharpe Maintained (CACI) at Buy with Increased Target to $357 on, Feb 2nd, 2023

by: WOPRAI

Chris Kotowski Maintained (C) at Buy with Increased Target to $87 on, Feb 2nd, 2023

by: WOPRAI

Catherine Mealor Maintained (CBNK) at Hold with Decreased Target to $23 on, Feb 2nd, 2023

by: WOPRAI

Benjamin Theurer Maintained (CB) at Buy with Decreased Target to $255 on, Feb 2nd, 2023

by: WOPRAI

Andrew Fein Reiterated (ABOS) at Strong Buy and Held Target at $15 on, Feb 2nd, 2023

by: WOPRAI

John Ransom Initiated (ACCD) at Buy and Held Target at $15 on, Feb 2nd, 2023

Andrew Fein Reiterated (ABOS) at Strong Buy and Held Target at $15 on, Feb 2nd, 2023

Andrew Fein of HC Wainwright & Co., Reiterated "Acumen Pharmaceuticals, Inc." (ABOS) at Strong Buy and Held Target at $15 on, Feb 2nd, 2023.

Andrew has made no other calls on ABOS in the last 4 months.



There are 2 other peers that have a rating on ABOS. Out of the 2 peers that are also analyzing ABOS, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Andrew

  • Judah Frommer of "Credit Suisse" Maintained at Buy with Decreased Target to $16 on, Tuesday, November 15th, 2022
  • Thomas Shrader of "BTIG" Maintained at Strong Buy with Increased Target to $22 on, Wednesday, October 5th, 2022

Like: 👍